|
NBR1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.534200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.019550E-01 |
| Normal-vs-Stage2 |
6.068000E-01 |
| Normal-vs-Stage3 |
2.884000E-03 |
| Normal-vs-Stage4 |
4.280100E-03 |
| Stage1-vs-Stage2 |
4.775600E-01 |
| Stage1-vs-Stage3 |
4.270400E-02 |
| Stage1-vs-Stage4 |
6.241600E-02 |
| Stage2-vs-Stage3 |
3.702000E-02 |
| Stage2-vs-Stage4 |
5.513600E-02 |
| Stage3-vs-Stage4 |
9.162400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.846160E-02 |
| Normal-vs-AfricanAmerican |
8.804200E-01 |
| Normal-vs-Asian |
2.317000E-01 |
| Caucasian-vs-AfricanAmerican |
1.335770E-01 |
| Caucasian-vs-Asian |
4.743200E-01 |
| AfricanAmerican-vs-Asian |
4.354600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.283700E-02 |
| Normal-vs-Female |
4.870400E-02 |
| Male-vs-Female |
3.965400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.941010E-01 |
| Normal-vs-Age(41-60Yrs) |
5.357700E-02 |
| Normal-vs-Age(61-80Yrs) |
1.023870E-02 |
| Normal-vs-Age(81-100Yrs) |
9.734000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.564400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.384760E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.840000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.971600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.110800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.194600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.334000E-02 |
| Classical-VS-Follicular |
8.901800E-01 |
| Classical-VS-Other |
1.518160E-01 |
| Classical-VS-Normal |
1.682780E-01 |
| Tall-VS-Follicular |
5.325700E-02 |
| Tall-VS-Other |
6.302200E-01 |
| Tall-VS-Normal |
2.844300E-03 |
| Follicular-VS-Other |
2.386000E-01 |
| Follicular-VS-Normal |
2.016400E-01 |
| Other-VS-Normal |
3.458300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.661500E-02 |
| Normal-vs-N1 |
9.718200E-03 |
| N0-vs-N1 |
1.773400E-01 |
|
|
